Anitha Anne

Associate
Full contact info

Experience

Carmot Therapeutics Enters Definitive Merger Agreement With Roche

December 3, 2023

Cooley advised Carmot Therapeutics, a clinical-stage biotechnology company dedicated to developing life-changing therapeutics for people living with metabolic diseases including obesity and diabetes, on its definitive merger agreement in which Roche will acquire Carmot.

Read more

Related contacts

Jamie Leigh
Partner, San Francisco
Ben Beerle
Partner, San Francisco
Charity Williams
Partner, San Diego
David Peinsipp
Partner, San Francisco
Kristin VanderPas
Partner, San Francisco
Lauren Creel
Partner, Palo Alto
Howard Morse
Partner, Washington, DC
Xander Lee
Partner, Los Angeles Santa Monica
Kathleen O'Neill
Partner, Washington, DC
Ross Eberly
Partner, Los Angeles Santa Monica
Barbara Mirza
Partner, Los Angeles Santa Monica
TJ Graham
Partner, Palo Alto
Christopher Kimball
Partner, Washington, DC
Tracy Rubin
Partner, Palo Alto
Phil Mitchell
Partner, New York
Charlie Kim
Partner, San Diego
Natasha Leskovsek
Of Counsel, Washington, DC
Christine Graham
Special Counsel, London
Stella Sarma
Special Counsel, Brussels
J. Brian Stalter
Special Counsel, New York
Jennifer Shanley
Special Counsel, New York
Grant Schweikert
Special Counsel, Washington, DC
Kristopher Kleiner
Special Counsel, Colorado
Dani Nazemian
Special Counsel, San Diego
Annie Froehlich
Partner, Washington, DC
Karen Tsai
Special Counsel, Washington, DC
Stacey A. Bradford
Special Counsel, Washington, DC
Sangitha Palaniappa
Associate, Palo Alto
Tyler McClure
Associate, San Francisco
Rubin Waranch
Associate, Washington, DC
Melissa Meza
Associate, San Diego
Jameson Davis
Associate, Palo Alto
Alexander Ellebracht
Associate, Palo Alto
Mor Agam
Associate, New York
Athina Gaki
Associate, Brussels
Andy Zachrich
Associate, San Diego
Dionne A. Thomas
Associate, San Diego
Umer Chaudhry
Associate, Washington, DC
Jane Jun
Associate, Palo Alto
Samara Zaifman
Associate, Palo Alto
Carly E. Gibbons
Associate, Chicago
Claire Norman
Associate, Palo Alto
Anitha Anne
Associate, San Francisco
Kristina Krasnikova
Associate, Palo Alto
Patricia Myers
Paralegal Specialist, Colorado
Loraine Torres
Paralegal Specialist, Colorado
Hitesh Patel
eDiscovery Attorney, Washington, DC

Related Practices & Industries

Turnstone Biologics Announces Upsized $80 Million IPO

July 26, 2023

Cooley advised Turnstone Biologics, a clinical-stage biotechnology company, on its upsized $80 million initial public offering.

Read more

Related contacts

Div Gupta
Partner, New York
Ryan Sansom
Partner, Boston
Lila Hope
Partner, Palo Alto
Valerie Sapozhnikova
Associate, Los Angeles Downtown
Julianne Orr
Associate, San Francisco
Anitha Anne
Associate, San Francisco
Cathy Rude
Paralegal Specialist, Boston
Natasha Leskovsek
Of Counsel, Washington, DC
Phil Mitchell
Partner, New York
Alessandra Murata
Partner, Palo Alto
Tony P. Guan
Associate, Los Angeles Santa Monica
Elizabeth Anne Wright
Partner, Brussels
Jessica Koffel
Associate, Brussels
Aaron Pomeroy
Partner, Colorado
Rick Jantz
Associate, Los Angeles Santa Monica
Xander Lee
Partner, Los Angeles Santa Monica
Francis Wheeler
Partner, Colorado

Related Practices & Industries

ACELYRIN Announces Pricing of Upsized Initial Public Offering

May 15, 2023

Cooley advised Acelyrin, INC., a late-stage biopharmaceutical company, in its $621 million initial public offering, the second-largest biotechnology IPO and largest clinical-stage biotechnology IPO ever.

Read more

Related contacts

Chadwick Mills
Partner, San Francisco
Charlie Kim
Partner, San Diego
Anitha Anne
Associate, San Francisco
Barbara Mirza
Partner, Los Angeles Santa Monica
Xander Lee
Partner, Los Angeles Santa Monica
Joshua Mates
Partner, San Francisco
Phil Mitchell
Partner, New York
Brad Goldberg
Partner, New York
Peter Adams
Partner, San Diego
Lauren Creel
Partner, Palo Alto
Koji Fukumura
Partner, San Diego
Patrick Gibbs
Partner, Palo Alto
David Peinsipp
Partner, San Francisco
Barbara Borden
Partner, San Diego
David Navetta
Partner, Colorado
Patrick Van Eecke
Partner, Brussels
Shannon Eagan
Partner in Charge – Palo Alto, Palo Alto
Darren DeStefano
Partner, Reston
Francis Wheeler
Partner, Colorado
Thomas Welk
Senior Counsel, San Diego
Natasha Leskovsek
Of Counsel, Washington, DC
Brett White
Of Counsel, Palo Alto
Dani Nazemian
Special Counsel, San Diego
Jennifer Shanley
Special Counsel, New York
Jacquelyn Burke
Special Counsel, Boston
Karen Tsai
Special Counsel, Washington, DC
Miriam Petrillo
Partner, Chicago
Andrew Nelms
Associate, San Francisco
David D. Kim
Associate, San Francisco
Lawrence Traylor
Associate, Los Angeles Santa Monica
Dionne A. Thomas
Associate, San Diego
Nathaniel Hearn Jr.
Associate, New York
Valerie Sapozhnikova
Associate, Los Angeles Downtown
Eileen Leman
Associate, Los Angeles Downtown
Kelly McCormick
Associate, San Francisco
Mor Agam
Associate, New York
Allison Kutner
Associate, New York
Madison (JJ) Meng
Associate, San Francisco
Rebecca Siegel
Associate, San Francisco
Rachel F. Katz
Associate, New York
Mari Dugas
Associate, Washington, DC
Loriane Sangaré-Vayssac
Associate, Brussels
Megan Drill
Associate, San Diego
Amanda Pacheco
Associate, Palo Alto
Kristin R. Marshall
Associate, Washington, DC
John T. Stellini
Associate, Palo Alto
Luke X. Blackett
Associate, San Francisco

Related Practices & Industries

AN2 Therapeutics – $79 Million IPO

March 25, 2022

Cooley advised AN2 Therapeutics on its $79 million initial public offering of 4,600,000 shares of common stock at a price to the public of $15.00 per share. AN2 is a clinical-stage biopharmaceutical company developing treatments for rare, chronic and serious infectious diseases with high unmet needs. Partner Josh Seidenfeld, associate Anitha Anne and Sally Kay of counsel led the Cooley team.

Related contacts

Josh Seidenfeld
Partner, Palo Alto
Anitha Anne
Associate, San Francisco
Sally Kay
Of Counsel, Palo Alto
Megan Ji
Associate, Seattle
Kristina Krasnikova
Associate, Palo Alto
Barbara Mirza
Partner, Los Angeles Santa Monica
Alexander Ellebracht
Associate, Palo Alto

Related Practices & Industries

Lyell Immunopharma – $425 Million IPO

July 20, 2021

Cooley advised Lyell Immunopharma, a T cell reprogramming company dedicated to the mastery of T cells to cure patients with solid tumors, on its $425 million initial public offering of 25,000,000 shares of its common stock. Partners Dave Peinsipp, Charlie Kim, Chad Mills and Lauren Creel led the Cooley team advising Lyell on its public debut, which marks the third largest biotech IPO in history.

Read more

Related contacts

David Peinsipp
Partner, San Francisco
Charlie Kim
Partner, San Diego
Chadwick Mills
Partner, San Francisco
Lauren Creel
Partner, Palo Alto
Allison Peth
Associate, Palo Alto
Kristina Krasnikova
Associate, Palo Alto
Anitha Anne
Associate, San Francisco
Bill Boyle
Paralegal Specialist, Palo Alto
Marya Postner
Partner, Palo Alto
Natasha Leskovsek
Of Counsel, Washington, DC
Phil Mitchell
Partner, New York
Jennifer Shanley
Special Counsel, New York
Barbara Mirza
Partner, Los Angeles Santa Monica
Austin Holt
Partner, Los Angeles Santa Monica
Mark Windfeld-Hansen
Senior Counsel, Palo Alto
Jonathan Rivinus
Partner, Colorado
Francis Wheeler
Partner, Colorado

Related Practices & Industries